| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |